Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 14 studies | 46% ± 18% | |
| astrocyte | 11 studies | 31% ± 14% | |
| oligodendrocyte precursor cell | 8 studies | 35% ± 16% | |
| GABAergic neuron | 7 studies | 31% ± 15% | |
| endothelial cell | 7 studies | 25% ± 7% | |
| microglial cell | 6 studies | 21% ± 6% | |
| glutamatergic neuron | 5 studies | 41% ± 18% | |
| interneuron | 5 studies | 32% ± 22% | |
| adipocyte | 4 studies | 27% ± 7% | |
| fibroblast | 4 studies | 28% ± 5% | |
| endothelial cell of lymphatic vessel | 4 studies | 21% ± 3% | |
| epithelial cell | 3 studies | 25% ± 3% | |
| macrophage | 3 studies | 21% ± 3% | |
| type I pneumocyte | 3 studies | 21% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 13 studies | 32% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 775.06 | 2638 / 2642 | 100% | 16.29 | 705 / 705 |
| prostate | 100% | 667.27 | 245 / 245 | 99% | 10.95 | 499 / 502 |
| breast | 100% | 563.18 | 459 / 459 | 98% | 9.07 | 1100 / 1118 |
| thymus | 100% | 724.65 | 653 / 653 | 98% | 7.50 | 591 / 605 |
| stomach | 100% | 430.69 | 359 / 359 | 95% | 5.92 | 271 / 286 |
| adrenal gland | 100% | 511.84 | 258 / 258 | 94% | 6.05 | 217 / 230 |
| ovary | 100% | 1054.81 | 180 / 180 | 92% | 5.63 | 397 / 430 |
| pancreas | 100% | 460.21 | 327 / 328 | 92% | 5.27 | 164 / 178 |
| bladder | 100% | 448.33 | 21 / 21 | 92% | 6.05 | 462 / 504 |
| intestine | 100% | 502.07 | 966 / 966 | 91% | 4.94 | 482 / 527 |
| lung | 100% | 511.81 | 578 / 578 | 91% | 5.67 | 1054 / 1155 |
| kidney | 100% | 341.09 | 89 / 89 | 88% | 5.07 | 797 / 901 |
| esophagus | 100% | 403.43 | 1440 / 1445 | 83% | 5.34 | 152 / 183 |
| skin | 98% | 314.15 | 1769 / 1809 | 81% | 4.41 | 381 / 472 |
| uterus | 100% | 535.66 | 170 / 170 | 71% | 4.06 | 324 / 459 |
| liver | 92% | 172.65 | 208 / 226 | 35% | 1.42 | 141 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 8.02 | 29 / 29 |
| spleen | 100% | 607.30 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.11 | 1 / 1 |
| adipose | 100% | 436.53 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 356.58 | 1325 / 1335 | 0% | 0 | 0 / 0 |
| heart | 98% | 342.67 | 843 / 861 | 0% | 0 | 0 / 0 |
| muscle | 88% | 170.67 | 708 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 70% | 315.87 | 652 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 58% | 2.05 | 26 / 45 |
| eye | 0% | 0 | 0 / 0 | 43% | 1.71 | 34 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZNF708 |
| Protein name | Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8) Zinc finger protein 708 |
| Synonyms | ZNF15L1 ZNF15 KOX8 |
| Description | FUNCTION: May be involved in transcriptional regulation. |
| Accessions | ENST00000601295.1 ENST00000598046.5 M0R2V2 M0R1G3 ENST00000602023.1 M0QYN4 ENST00000356929.3 P17019 |